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found. Compared with the LA group, more patients in the AD 
group, were treated with IMRT; 17% vs. 6% (p<0.01), and 
nodal boost - 22% vs. 13% (p <0.01). For brachytherapy, more 
patients in the AD group were treated with HDR BT; 66% vs. 
52% (p<0.01), combined IC/IS technique - 47% vs. 4% 
(p<0.01), and MRI based dose planning - 97% vs. 66% 
(p<0.01).Compared with the LA group, average HR CTV 
volume was 6cm3 larger and average D90 for HR CTV was 9 Gy 
higher in the AD group (p<0.01). This target dose difference 
did not result in higher D2cm³, for rectum (p=0.12) or 
sigmoid (p=0.38) in the AD group. D2cm³ for bladder was on 
average 4 Gy lower in the AD group (p=0.07) (table 1). 
At a median follow-up of 40 (3-163) months no significant 
difference in late actuarial grade 2 to 5 bladder (p=0.63), 
gastro-intestinal (p=0.81) or vaginal morbidity (p=0.10) was 
found between the LD and AD groups. 
 
 
Conclusions: Advanced adaptation with combined IC/IS 
technique enables delivery of significantly higher radiation 
doses to the HR CTV D90 without increasing the D2cm³ to 
organs at risk or adding more late morbidity to treatment.  
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Purpose/Objective: In our department, an adaptive 
radiotherapy protocol is used for laryngeal cancer patients 
treated with IMRT on the larynx as well as the bilateral 
(elective) lymph nodes. The goal was to investigate the 
clinical feasibility and the impact of this protocol.  
Materials and Methods: Twenty-seven patients were 
included. During fraction 1-4 in week 1, and in three 
fractions in the weeks thereafter, a CBCT was acquired. For 
each CBCT, an automatic gray value registration based on a 
clipbox around the cervical vertebrae was performed using 
the Elekta XVI software (version 4.5.1). Setup corrections 
were performed following the extended No Action Level 
(eNAL) protocol1. Technologists evaluated the position of the 
larynx relative to the PTV and the laryngeal bony structures, 
after the correction based on the vertebrae. If a 
displacement of 5 mm or more was seen, the physician was 
contacted to decide whether or not a new planning CT-scan 
and adaptive re-planning were required (CTV-PTV margin of 5 
mm). The impact of this protocol on larynx set-up variations 
and resulting margins were assessed.  
Results: In a recent study2 it was demonstrated that due to 
non-rigid motion in larynx cancer patients, applying the eNAL 
protocol with once a week follow-up imaging and omitting 
the above described approach for plan adaptation, a 5 mm 
CTV-PTV margin for the larynx was not sufficiently large in 
the cranial-caudal (CC) direction (see Table 1). In the new 
protocol, apart from three times a week imaging and 
adaptive re-planning, the patients also got swallowing 
instructions during CT, CBCT and irradiation. For 11/27 
patients one or more new planning CTs were made. This 
resulted in smaller calculated margins than in the previous 
study (Table 1). 
Table 1: Population mean (m), random (s), and systematic (S) 
set-up errors and calculated CTV-PTV margins3. 
 
 eNAL (2012)2  eNAL + adaptive re-
planning (2014) 
LR(mm) CC(mm) AP(mm) LR(mm) CC(mm) AP(mm) 
µ  -0.3 0.3 0.8 -0.3 -0.4 0.4 
σ  2.0 2.8 2.0 1.2 2.6 1.9 
∑ 0.9 2.8 1.0 0.8 1.6 1.0 
Margin33.2 7.6 3.5 2.4 5.0 3.2 
 
Conclusions: Based on a clear decision protocol for the 
technologists, adaptive treatment of laryngeal cancer 
patients was successfully implemented in the clinical routine. 
The approach effectively reduced CTV-PTV-margins. New 
patients are currently being entered in the study and will be 
included in the final analyses. 
1. IJROBP 2007, 1586–1595 
2. IJROBP 2013, 401-406 
3. IJROBP 1999, 905-919  
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Purpose/Objective: Large changes in bladder shape and size 
during a course of radiotherapy (RT) make adaptive RT (ART) 
appealing in the treatment of this tumor site. We are 
conducting a multi-center clinical phase II trial of daily plan 
selection based ART for bladder cancer with the primary aim 
of reducing gastro-intestinal morbidity due to sparing of the 
bowel and the rectum. We here report early dose/volume 
outcomes from the first twenty patients treated in this trial. 
Materials and Methods: All twenty patients received 60 Gy in 
30 fractions to the bladder; in 13 of the patients the pelvic 
lymph nodes were simultaneously treated to 48 Gy. Cone-
beam CT (CBCT) image guidance was used for daily set-up 
and treatment was delivered by volumetric modulated arc 
therapy (VMAT). The first five fractions were delivered using 
large, population-based margins; the bladder contours from 
the CBCTs acquired prior to the first four fractions were used 
to create a library of three plans, corresponding to a small, 
medium and large size bladder. All patients were from 
fraction no. 6 treated using daily online plan selection, where 
the smallest plan covering the bladder was selected prior to 
each treatment delivery. Volume ratios of PTV for ART vs. 
non-ART averaged over the treatment course were 
calculated. DVHs for bowel cavity and rectum were derived 
by summation of the selected dose plans on the planning CT 
and these were compared to standard non-adaptive RT plans 
using population-based margins (20 mm Sup/Ant, 15 mm Post 
and 10 mm LR and Inf). 
